Modelling the endothelial blood-CNS barriers: a method for the production of robust in vitro models of the rat blood-brain barrier and blood-spinal cord barrier by Watson, P Marc D, Paterson, Judy C, Thom, George, Ginman, Ulrika, Lundquist, Stefan, Webster, Carl I

Get full text

Modelling the endothelial blood-CNS barriers: a method for the production of robust in vitromodels of the rat blood-brain barrier and blood-spinal cord barrier by Watson, P Marc D, Paterson, Judy C, Thom, George, Ginman, Ulrika, Lundquist, Stefan, Webster, Carl I

Get full text

2-weekly versus 3-weekly docetaxel to treat castration-resistant advanced prostate cancer: a randomised, phase 3 trial by Kellokumpu-Lehtinen, Pirkko-Liisa, Prof, Harmenberg, Ulrika, MD, Joensuu, Timo, MD, McDermott, Ray, MD, Hervonen, Petteri, MD, Ginman, Claes, MD, Luukkaa, Marjaana, MD, Nyandoto, Paul, MD, Hemminki, Akseli, Prof, Nilsson, Sten, Prof, McCaffrey, John, Prof, Asola, Raija, MD, Turpeenniemi-Hujanen, Taina, Prof, Laestadius, Fredrik, MD, Tasmuth, Tiina, MD, Sandberg, Katinka, MD, Keane, Maccon, MD, Lehtinen, Ilari, BSc, Luukkaala, Tiina, MSc, Joensuu, Heikki, Prof

Get full text

Creation of a Novel Class of Potent and Selective MutT Homologue 1 (MTH1) Inhibitors Using Fragment-Based Screening and Structure-Based Drug Design by Rahm, Fredrik, Viklund, Jenny, Trésaugues, Lionel, Ellermann, Manuel, Giese, Anja, Ericsson, Ulrika, Forsblom, Rickard, Ginman, Tobias, Günther, Judith, Hallberg, Kenth, Lindström, Johan, Persson, Lars Boukharta, Silvander, Camilla, Talagas, Antoine, Díaz-Sáez, Laura, Fedorov, Oleg, Huber, Kilian V. M, Panagakou, Ioanna, Siejka, Paulina, Gorjánácz, Mátyás, Bauser, Marcus, Andersson, Martin

Get full text

Novel Class of Potent and Cellularly Active Inhibitors Devalidates MTH1 as Broad-Spectrum Cancer Target by Ellermann, Manuel, Eheim, Ashley, Rahm, Fredrik, Viklund, Jenny, Guenther, Judith, Andersson, Martin, Ericsson, Ulrika, Forsblom, Rickard, Ginman, Tobias, Lindström, Johan, Silvander, Camilla, Trésaugues, Lionel, Giese, Anja, Bunse, Stefanie, Neuhaus, Roland, Weiske, Jörg, Quanz, Maria, Glasauer, Andrea, Nowak-Reppel, Katrin, Bader, Benjamin, Irlbacher, Horst, Meyer, Hanna, Queisser, Nina, Bauser, Marcus, Haegebarth, Andrea, Gorjánácz, Mátyás

Get full text

Biweekly Docetaxel Is Better Tolerated than Conventional Three-weekly Dosing for Advanced Hormone-refractory Prostate Cancer by HERVONEN, Petteri, JOENSUU, Heikki, MIRJA, Heikkinen, STEN, Nilsson, MARJAANA, Luukkaa, ILARI, Lehtinen, PIRKKO-LIISA, Kellokumpu-Lehtinen, JOENSUU, Timo, CLAES, Ginman, RAY, Mcdermott, ULRIKA, Harmenberg, PAUL, Nyandoto, TIINA, Luukkaala, AKSELI, Hemminki, IGOR, Zaitsev

Get full text

Development of Inhibitors of PIP4K2 As a Treatment for Patients with Hematologic Malignancies by McElligott, David L, Kesicki, Edward, Karukarichi, Kannan, Shim, Hyeseok, Wang, Rui, Yu, Albert S., Zolfaghari, Parisa, Linstrom, Johan, Persson, Lars, Hoglund, Andreas, Ericsson, Ulrika, Trésaugues, Lionel, Livendahl, Madeleine, Santangelo, Ellen, Viklund, Jenny, Pettersson, Mariell, Wähling, Horst, Forsblom, Rickard, Karlsson, Fredrik, Ginman, Tobias, Braga, Tiago, Henley, Aine Brigette, Talagas, Antoine, Rahm, Fredrik, Johansson, Tommy, Martinsson, Jessica, Andersson, Martin, Cantley, Lewis

Get full text